What medications are not classified as typical antipsychotics?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Medications that are not typical antipsychotics include lithium, benzodiazepines, and anticonvulsants, as their antipsychotic properties are not well-established, and they are not primarily used as antipsychotics 1.

Key Points

  • Typical antipsychotics, also known as first-generation antipsychotics, include medications such as haloperidol, chlorpromazine, fluphenazine, perphenazine, thioridazine, and trifluoperazine 1.
  • Atypical antipsychotics, also known as second-generation antipsychotics, include medications such as clozapine, risperidone, olanzapine, quetiapine, and others 1.
  • The distinction between typical and atypical antipsychotics is important because they differ in their mechanism of action and side effect profiles 1.
  • Lithium, benzodiazepines, and anticonvulsants may have some reported efficacy for schizophrenia in adults, but their use in youth with schizophrenia has not been studied, and their antipsychotic activity is limited 1.

Mechanism of Action and Side Effects

  • Typical antipsychotics primarily block dopamine D2 receptors and often cause significant extrapyramidal symptoms (EPS) like parkinsonism, akathisia, and tardive dyskinesia 1.
  • Atypical antipsychotics generally have broader receptor activity, including serotonin receptors, and typically cause fewer EPS but may have different side effects such as metabolic issues (weight gain, diabetes risk) and sedation 1.

Clinical Considerations

  • When prescribing antipsychotics, it's essential to consider the specific symptom profile of the patient and potential side effects of each medication class 1.
  • Systematic studies are needed to establish the efficacy and safety of atypical antipsychotic medications in juveniles 1.

From the FDA Drug Label

Atypical antipsychotic drugs, including clozapine have been associated with metabolic changes that can increase cardiovascular and cerebrovascular risk. Atypical antipsychotic drugs have been associated with metabolic changes that include hyperglycemia/diabetes mellitus, dyslipidemia, and body weight gain.

The medications that are not typical antipsychotics are atypical antipsychotics, which include:

  • Clozapine 2
  • Quetiapine 3

From the Research

Medications Not Classified as Typical Antipsychotics

The following medications are not typical antipsychotics:

  • Aripiprazole
  • Clozapine
  • Lurasidone
  • Olanzapine
  • Quetiapine
  • Risperidone

Characteristics of Atypical Antipsychotics

Atypical antipsychotics differ from typical antipsychotics in their pharmacology, efficacy, and adverse effects 4, 5. They have a "limbic-specific" dopamine type 2 (D2)-receptor binding and a high ratio of serotonin type 2 (5-HT2)-receptor binding to D2 binding 5.

Comparison with Typical Antipsychotics

Atypical antipsychotics are often more effective than typical antipsychotics in treating negative symptoms, cognitive impairment, and mood symptoms, as well as reducing the risk for suicide and decreasing aggression 4. They are also associated with a decreased capacity to cause extrapyramidal side effects, tardive dyskinesia, neuroleptic malignant syndrome, and hyperprolactinemia 5.

Use in Treatment-Resistant Schizophrenia

Atypical antipsychotics, such as aripiprazole, lurasidone, olanzapine, and risperidone, can be more effective than typical antipsychotics for treatment-resistant schizophrenia 4. Clozapine is uniquely indicated for reducing the risk for suicide 4.

Other Indications

Atypical antipsychotics are increasingly being used for indications other than schizophrenia, such as the management of aggression, mania, and depression 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Contrasting Typical and Atypical Antipsychotic Drugs.

Focus (American Psychiatric Publishing), 2021

Research

Atypical antipsychotic agents: a critical review.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.